The impact of long-term lenalidomide exposure on the cellular composition of bone marrow

被引:2
作者
Brioli, Annamaria [1 ,4 ]
Melchor, Lorenzo [1 ]
Titley, Ian [2 ]
Vijayaraghavan, Gowri [3 ]
Stephens, Claire [5 ]
Zeisig, Athanasia [5 ]
Pawlyn, Charlotte [1 ]
Cavo, Michele [4 ]
Morilla, Ricardo [5 ]
Davies, Faith E. [1 ]
Morgan, Gareth J. [1 ]
机构
[1] Inst Canc Res, Myeloma Res Ctr, Div Mol Pathol, London SW3 6JB, England
[2] Inst Canc Res, Ctr Evolut & Canc, London SW3 6JB, England
[3] Inst Canc Res, Div Canc Therapeut, London SW3 6JB, England
[4] Univ Bologna, Policlin S Orsola Malpighi, Ist Ematol Seragnoli, Bologna, Italy
[5] Royal Marsden Hosp, Ctr Mol Pathol, Immunophenotyping Unit, London SW3 6JJ, England
关键词
DIAGNOSED MULTIPLE-MYELOMA; TRANSPLANTATION; THALIDOMIDE; DEXAMETHASONE; BORTEZOMIB; LEUKEMIA; THERAPY; DISEASE;
D O I
10.3109/10428194.2014.900765
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2665 / 2668
页数:4
相关论文
共 15 条
[1]   Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma [J].
Attal, Michel ;
Lauwers-Cances, Valerie ;
Marit, Gerald ;
Caillot, Denis ;
Moreau, Philippe ;
Facon, Thierry ;
Stoppa, Anne Marie ;
Hulin, Cyrille ;
Benboubker, Lofti ;
Garderet, Laurent ;
Decaux, Olivier ;
Leyvraz, Serge ;
Vekemans, Marie-Christiane ;
Voillat, Laurent ;
Michallet, Mauricette ;
Pegourie, Brigitte ;
Dumontet, Charles ;
Roussel, Murielle ;
Leleu, Xavier ;
Mathiot, Claire ;
Payen, Catherine ;
Avet-Loiseau, Herve ;
Harousseau, Jean-Luc .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1782-1791
[2]   Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study [J].
Cavo, Michele ;
Tacchetti, Paola ;
Patriarca, Francesca ;
Petrucci, Maria Teresa ;
Pantani, Lucia ;
Galli, Monica ;
Di Raimondo, Francesco ;
Crippa, Claudia ;
Zamagni, Elena ;
Palumbo, Antonio ;
Offidani, Massimo ;
Corradini, Paolo ;
Narni, Franco ;
Spadano, Antonio ;
Pescosta, Norbert ;
Deliliers, Giorgio Lambertenghi ;
Ledda, Antonio ;
Cellini, Claudia ;
Caravita, Tommaso ;
Tosi, Patrizia ;
Baccarani, Michele .
LANCET, 2010, 376 (9758) :2075-2085
[3]   Lenalidomide mode of action: linking bench and clinical findings [J].
Davies, Faith ;
Baz, Rachid .
BLOOD REVIEWS, 2010, 24 :S13-S19
[4]   International uniform response criteria for multiple myeloma [J].
Durie, B. G. M. ;
Harousseau, J-L ;
Miguel, J. S. ;
Blade, J. ;
Barlogie, B. ;
Anderson, K. ;
Gertz, M. ;
Dimopoulos, M. ;
Westin, J. ;
Sonneveld, P. ;
Ludwig, H. ;
Gahrton, G. ;
Beksac, M. ;
Crowley, J. ;
Belch, A. ;
Boccadaro, M. ;
Turesson, I. ;
Joshua, D. ;
Vesole, D. ;
Kyle, R. ;
Alexanian, R. ;
Tricot, G. ;
Attal, M. ;
Merlini, G. ;
Powles, R. ;
Richardson, P. ;
Shimizu, K. ;
Tosi, P. ;
Morgan, G. ;
Rajkumar, S. V. .
LEUKEMIA, 2006, 20 (09) :1467-1473
[5]   Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis [J].
Koh, KR ;
Janz, M ;
Mapara, MY ;
Lemke, B ;
Stirling, D ;
Dörken, B ;
Zenke, M ;
Lentzsch, S .
BLOOD, 2005, 105 (10) :3833-3840
[6]   Risk of acute myeloid leukemia and myelodysplastic syndromes after multiple myeloma and its precursor disease (MGUS) [J].
Mailankody, Sham ;
Pfeiffer, Ruth M. ;
Kristinsson, Sigurdur Y. ;
Korde, Neha ;
Bjorkholm, Magnus ;
Goldin, Lynn R. ;
Turesson, Ingemar ;
Landgren, Ola .
BLOOD, 2011, 118 (15) :4086-4092
[7]   Myelodysplasia-associated immunophenotypic alterations of bone marrow cells in myeloma: are they present at diagnosis or are they induced by lenalidomide? [J].
Matarraz, Sergio ;
Paiva, Bruno ;
Diez-Campelo, Maria ;
Corral, Lucia-Lopez ;
Perez, Estefania ;
Mateos, Maria-Victoria ;
Giraldo, Pilar ;
Hernandez, Miguel T. ;
San Miguel, Jesus F. ;
Orfao, Alberto .
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (10) :1608-1611
[8]   Lenalidomide after Stem-Cell Transplantation for Multiple Myeloma [J].
McCarthy, Philip L. ;
Owzar, Kouros ;
Hofmeister, Craig C. ;
Hurd, David D. ;
Hassoun, Hani ;
Richardson, Paul G. ;
Giralt, Sergio ;
Stadtmauer, Edward A. ;
Weisdorf, Daniel J. ;
Vij, Ravi ;
Moreb, Jan S. ;
Callander, Natalie Scott ;
Van Besien, Koen ;
Gentile, Teresa ;
Isola, Luis ;
Maziarz, Richard T. ;
Gabriel, Don A. ;
Bashey, Asad ;
Landau, Heather ;
Martin, Thomas ;
Qazilbash, Muzaffar H. ;
Levitan, Denise ;
McClune, Brian ;
Schlossman, Robert ;
Hars, Vera ;
Postiglione, John ;
Jiang, Chen ;
Bennett, Elizabeth ;
Barry, Susan ;
Bressler, Linda ;
Kelly, Michael ;
Seiler, Michele ;
Rosenbaum, Cara ;
Hari, Parameswaran ;
Pasquini, Marcelo C. ;
Horowitz, Mary M. ;
Shea, Thomas C. ;
Devine, Steven M. ;
Anderson, Kenneth C. ;
Linker, Charles .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (19) :1770-1781
[9]   Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation [J].
Morgan, Gareth J. ;
Davies, Faith E. ;
Gregory, Walter M. ;
Russell, Nigel H. ;
Bell, Sue E. ;
Szubert, Alexander J. ;
Coy, Nuria Navarro ;
Cook, Gordon ;
Feyler, Sylvia ;
Byrne, Jenny L. ;
Roddie, Huw ;
Rudin, Claudius ;
Drayson, Mark T. ;
Owen, Roger G. ;
Ross, Fiona M. ;
Jackson, Graham H. ;
Child, J. Anthony .
BLOOD, 2011, 118 (05) :1231-1238
[10]   Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia [J].
Pal, Rekha ;
Monaghan, Sara A. ;
Hassett, Andrea Cortese ;
Mapara, Markus Y. ;
Schafer, Peter ;
Roodman, G. David ;
Ragni, Margaret V. ;
Moscinski, Lynn ;
List, Alan ;
Lentzsch, Suzanne .
BLOOD, 2010, 115 (03) :605-614